Br. Walker et al., REGULATION OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE-ACTIVITY BY THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS IN THE RAT, Journal of Endocrinology, 141(3), 1994, pp. 467-472
11 beta-Hydroxysteroid dehydrogenase (11 beta-OHSD) inactivates glucoc
orticoids and thereby modulates their access to both mineralocorticoid
and glucocorticoid receptors. Since 11 beta-OHSD activity influences
the biological responses of the hypothalamic-pituitary-adrenal axis, i
t might be regulated by components of this axis. We examined 11 beta-O
HSD activity in adrenalectomized rats treated for 9 days with dexameth
asone and with or without ACTH. Adrenalectomy and low-dose (2 mu g/day
) dexamethasone had no effect on 11 beta-OHSD activity in renal cortex
, hippocampus or heart, and reduced enzyme activity in aorta. High-dos
e dexamethasone (50 mu g/day) had no effect in renal cortex but increa
sed enzyme activity by at least 50% in all other sites. This effect of
dexamethasone was unaffected by the co-administration of ACTH. We als
o examined the metabolism of dexamethasone by 11 beta-OHSD in homogeni
zed rat tissues. Only in kidney, in the presence of NAD rather than NA
DP, was dexamethasone converted to a more polar metabolite previously
identified as 11-dehydrodexamethasone. We conclude that: dexamethasone
induction of 11 beta-OHSD is tissue-specific, and includes vascular t
issues and hippocampus but not kidney; this tissue-specificity may be
explained by contrasting metabolism of dexamethasone by the isoforms o
f 11 beta-OHSD; fluctuations of glucocorticoid levels within the physi
ological range may not have a biologically significant effect on 11 be
ta-OHSD activity; and the inhibitory effect of ACTH, observed previous
ly in humans, is Likely to depend on the presence of intact adrenal gl
ands.